XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.1

Revenues (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three months ended March 31, 2021 and 2020:

			Three months ended March 31,
			2021						2020
Products:
Kristalose			$	2,994,378					$	3,311,696
Vibativ			5,052,243						2,425,755
Caldolor			1,539,496						1,096,291
Acetadote			117,191						713,899
Omeclamox-Pak			(450,263)						114,770
Vaprisol			1,134,264						208,763
RediTrex			(32,252)						—
Other revenue			182,102						459,560
Total net revenues			$	10,537,159					$	8,330,734

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration